Loading...
935106861
info@markelab.com
Precio
375€ (100 µg)
Zenocutuzumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting ERBB2/ERBB3, Zenocutuzumab is under investigation in clinical trial NCT03321981 (MCLA-128 With Trastuzumab/chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer).
Biosimilars
Human
Monoclonal
Human
ERBB2/ERBB3
Human
IgG1 Kappa
Unconjugated
Liquid
ELISA, WB
100 µg
1 mg
Recombinant
> 95%
Purified from cell culture supernatants by Protein A/G chromatography.
0.01 M PBS. pH 7.4.
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
No
Shipped within 7-12 working days.
Biosimilars
CAS Number 1969309-56-5
Precio a consultar
Ver másPrecio a consultar
Ver másPrecio a consultar
Ver más